skip to Main Content

Oxford-Pomezia vaccine, the UK reserves 30 million doses

Oxford-Pomezia Vaccine, The UK Reserves 30 Million Doses
fonte foto: Il Messaggero

Il Messaggero

Great Britain is purchasing 30 million doses of the Coronavirus vaccine developed by the University of Oxford in collaboration with the Italian Advent-IRBM, based in Pomezia (Rome). “The product development is really positive at present. The time has been unbelievably shortened and there is a good chance to have a significant number of doses within the end of September, when we will find out if the vaccine candidate will become a vaccine”, explains Di Lorenzo, President and CEO of IRBM.

Article published on Il Messaggero – 18/05/2020

Read the original article on

Back To Top